Search

Displaying results 6591 - 6600 of 8575 in total
  1. Drug

    Sapanisertib

    go.drugbank.com/drugs/DB11836
    Investigational

    Sapanisertib has been used in trials studying the treatment of HCC, Solid Tumor, Gliosarcoma, Liver Cancer, and Glioblastoma, among others.

  2. Drug

    STC3141

    go.drugbank.com/drugs/DB16475
    Investigational

    STC3141, was investigated in clinical trial NCT04880694 to evaluate its safety and effect in subjects with severe COVID-19 pneumonia.

  3. Drug

    Branebrutinib

    go.drugbank.com/drugs/DB15347
    Investigational

    Branebrutinib is under investigation in clinical trial NCT02705989 (Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects).

    Synonyms: BMS-986195
  4. Drug

    GSK-364735

    go.drugbank.com/drugs/DB13119
    Investigational

    GSK-364735 (Naphthyridinone) has been used in trials studying the treatment of HIV-1 Infection and Infection, Human Immunodeficiency Virus.

  5. Drug

    Lenomorelin

    go.drugbank.com/drugs/DB11895
    Investigational

    Lenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.

  6. Drug

    Varespladib

    go.drugbank.com/drugs/DB11909
    Investigational

    Varespladib has been investigated for the treatment and prevention of Sickle Cell Disease, Vaso-occlusive Crisis, and Acute Coronary Syndrome.

  7. Drug

    AZD-1236

    go.drugbank.com/drugs/DB11961
    Investigational

    AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

  8. Drug

    BMS-986094

    go.drugbank.com/drugs/DB11966
    Investigational

    INX-08189 has been used in trials studying the treatment of Hepatitis C, HCV (Genotype 1), and Hepatitis C Virus.

  9. Drug

    Rilotumumab

    go.drugbank.com/drugs/DB11972
    Investigational

    Rilotumumab has been investigated for the treatment of Cancer, Lung Cancer, Solid Tumors, Gastric Cancer, and Prostate Cancer, among others.

  10. Drug

    TAK-448

    go.drugbank.com/drugs/DB11975
    Investigational

    TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.